Belize vs Russian Federation: Average cost of multi drug-resistant tuberculosis treatment
Belize
3,017 constant 2022 US$
in 2024
Russian Federation
2,751 constant 2022 US$
in 2024
Belize rank
15th
Russian Federation rank
18th
Average cost of multi drug-resistant tuberculosis treatment over time
- Belize
- Russian Federation
How they compare
Belize currently reports 3,017 constant 2022 US$ against 2,751 constant 2022 US$ in Russian Federation, a difference of 266 constant 2022 US$.
That makes Belize's figure about 1.1 times Russian Federation's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Belize ahead.
Belize ranks 15th and Russian Federation ranks 18th of 92 countries.
Across the 2 decades both report, Belize averaged higher in 1 and Russian Federation in 1.
Head to head by decade
| Decade | Belize | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3,334 constant 2022 US$ | 2,807 constant 2022 US$ | 527 constant 2022 US$ | Belize |
| 2020s | 2,000 constant 2022 US$ | 2,819 constant 2022 US$ | 818.5 constant 2022 US$ | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Belize or Russian Federation?
- Belize, at 3,017 constant 2022 US$ against 2,751 constant 2022 US$ in Russian Federation as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Belize and Russian Federation?
- 266 constant 2022 US$, with Belize ahead.
- How many years of comparable data are there for Belize and Russian Federation?
- 6 years are reported by both, from 2017 to 2024.
- How do Belize and Russian Federation rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Belize ranks 15th and Russian Federation ranks 18th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.